These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7542004)

  • 1. Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome.
    Bell SA; Du Clos TW; Khursigara G; Picazo JJ; Rubin RL
    J Autoimmun; 1995 Apr; 8(2):293-303. PubMed ID: 7542004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The toxic oil syndrome: an example of an exogenously induced autoimmune reaction. Toxic oil syndrome.
    Bell SA
    Mol Biol Rep; 1996; 23(3-4):261-3. PubMed ID: 9112238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.
    Bell SA; Faust H; Schmid A; Meurer M
    Clin Exp Immunol; 1998 Sep; 113(3):327-32. PubMed ID: 9737658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The toxic oil syndrome: a perspective on immunotoxicological mechanisms.
    Yoshida SH; German JB; Fletcher MP; Gershwin ME
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):60-79. PubMed ID: 8159816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic oil syndrome--an example of an exogenously-induced autoimmune disease].
    Bell S; Brand K; Meurer M
    Hautarzt; 1992 Jun; 43(6):339-43. PubMed ID: 1628965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DR2 antigens are associated with severity of disease in toxic oil syndrome (TOS).
    Cárdaba B; Ezendam J; Gallardo S; del Pozo V; Izquierdo M; Martín C; Cortegano I; Aceituno E; Rojo M; Arrieta I; Palomino P; Posada M; Lahoz C
    Tissue Antigens; 2000 Feb; 55(2):110-7. PubMed ID: 10746782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of the alimentary toxic oil syndrome due to ingestion of denatured rapeseed oil.
    Gilsanz V; Alvarez JL; Serrano S; Simón J
    Arch Intern Med; 1984 Feb; 144(2):254-6. PubMed ID: 6696559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.
    Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR
    Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C; Wetterö J
    Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds.
    Kammüller ME; Bloksma N; Seinen W
    J Toxicol Clin Toxicol; 1988; 26(3-4):157-74. PubMed ID: 3047417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological basis of toxic oil syndrome (TOS).
    Gallardo S; del Pozo V; Cárdaba B; de Andrés B; Martín-Orozco E; Fernandez JC; Tramón P; Posada M; Abaitua I; Palomino P
    Toxicology; 1994 Nov; 93(2-3):289-99. PubMed ID: 7974520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome.
    Bell SA; Hobbs MV; Rubin RL
    J Immunol; 1992 Jun; 148(11):3369-76. PubMed ID: 1588038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The toxic oil syndrome: a continuing challenge.
    Diggle GE
    Adverse Drug React Toxicol Rev; 1995; 14(1):11-35. PubMed ID: 7612780
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigating the onset of autoimmunity in A.SW mice following treatment with 'toxic oils'.
    Weatherill AR; Stang BV; O'Hara K; Koller LD; Hall JA
    Toxicol Lett; 2003 Jan; 136(3):205-16. PubMed ID: 12505274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel human autoantibodies to phosphoepitopes on mitotic chromosomal autoantigens (MCAs).
    Gitlits VM; Macaulay SL; Toh BH; Sentry JW
    J Investig Med; 2000 May; 48(3):172-82. PubMed ID: 10822897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS).
    Messeguer A
    Chem Biol Interact; 2011 Jun; 192(1-2):136-41. PubMed ID: 20970410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease.
    Vaughan JH; Nguyen MD; Valbracht JR; Patrick K; Rhodes GH
    J Clin Invest; 1995 Mar; 95(3):1316-27. PubMed ID: 7533789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunogens, autoantigens, autoantibodies and autoimmune diseases: one-to-one or many-to-many relationships?
    Billings PB
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):67-79. PubMed ID: 2441720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manufacturing processes at two French rapeseed oil companies: possible relationships to toxic oil syndrome in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Bernert JT; Gancedo JC; DuClos PJ; Kilbourne EM
    Food Chem Toxicol; 1991 Dec; 29(12):797-803. PubMed ID: 1765323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Examination of acute phase proteins concentrations in children with allergic rhinitis].
    Steiner I; Sobieska M; Pucher B; Grzegorowski M; Samborski W
    Ann Acad Med Stetin; 2006; 52(2):33-7; discussion 37. PubMed ID: 17633124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.